U.S. NIH director says will not compromise on coronavirus vaccine safety

(Reuters) - The pause of AstraZeneca Plc's coronavirus vaccine trials due to an unexplained illness in a study participant shows that safety of vaccines will not be compromised, the head of the National Institutes of Health told a U.S. Congress panel on Wednesday.

Reuters September 10, 2020 00:10:47 IST
U.S. NIH director says will not compromise on coronavirus vaccine safety

coronavirus vaccine safety" src="https://images.firstpost.com/wp-content/uploads/reuters/09-2020/10/2020-09-09T172429Z_1_LYNXMPEG881NF_RTROPTP_2_HEALTH-CORONAVIRUS-USA-CONGRESS.jpg" alt="US NIH director says will not compromise on coronavirus vaccine safety" width="300" height="225" />

(Reuters) - The pause of AstraZeneca Plc's coronavirus vaccine trials due to an unexplained illness in a study participant shows that safety of vaccines will not be compromised, the head of the National Institutes of Health told a U.S. Congress panel on Wednesday.

AstraZeneca said it had paused global trials, including large late-stage trials, of the experimental vaccine following the development to allow an independent committee to review safety data.

The NIH is providing funding for the company's vaccine trial.

"I want to address concerns about safety. This is foremost in our minds. We cannot compromise here," said NIH's Director Francis Collins at a hearing by the Senate Health, Education, Labor and Pensions Committee.

The halt was the "best sort of cautious approach to quickly stop and look and see if there's any other evidence to be concerned about," Collins added.

Also on Wednesday, the U.S. surgeon general Jerome Adams said at the hearing that the U.S. health department had issued guidance that would allow state-licensed pharmacists to administer coronavirus vaccines once they are available.

(Reporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Alphabet's Waymo partners with Google Maps to offer autonomous rides
Business

Alphabet's Waymo partners with Google Maps to offer autonomous rides

(Reuters) - Alphabet Inc's self-driving unit Waymo said on Thursday it had partnered with Google's Maps to let users book fully autonomous ride-hailing services through the app.

Tesla revises plans for German gigafactory with more details on product lines
Business

Tesla revises plans for German gigafactory with more details on product lines

FRANKFURT (Reuters) - Tesla on Thursday revised its application for a planned gigafactory in Europe to include details for plans to produce battery cells on site and an expansion of other production lines, German officials said. It also includes plans to reduce water consumption so that usage remains constant compared to earlier proposals despite the expansion. Tesla has sharply criticised the lengthy regulatory processes in Germany and has pushed back the factory's opening date.

Facebook ready to commit to clear ad data access for partners, French watchdog says
Business

Facebook ready to commit to clear ad data access for partners, French watchdog says

By Mathieu Rosemain PARIS (Reuters) - U.S. social media giant Facebook has offered to commit to providing its partners with clear and objective conditions of access to advertising inventories and ad campaign data, France's antitrust authority said on Thursday following an investigation.